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Abstract: 1 
Computer models allow the mechanistically detailed study of tumour proliferation and its 2 
dependency on nutrients. However, the computational study of large vascular tumours requires 3 
detailed information on the 3-dimensional vessel network and rather high computation times 4 
due to complex geometries. This study puts forward the idea of partitioning vascularised tissue 5 
into connected avascular elements that can exchange cells and nutrients between each other. 6 
Our method is able to rapidly calculate the evolution of proliferating as well as dead and 7 
quiescent cells, and hence a proliferative index, from a given amount and distribution of 8 
vascularisation of arbitrary complexity. Applying our model, we found that a heterogeneous 9 
vessel distribution provoked a higher proliferative index, suggesting increased malignancy, and 10 
increased the amount of dead cells compared to a more static tumour environment when a 11 
homogenous vessel distribution was assumed. We subsequently demonstrated that under 12 
certain amounts of vascularisation, cell proliferation may even increase when vessel density 13 
decreases, followed by a subsequent decrease of proliferation. This effect was due to a trade-14 
off between an increase in compensatory proliferation for replacing dead cells and a decrease 15 
of cell population due to lack of oxygen supply in lowly vascularised tumours. Findings were 16 
illustrated by an ectopic colorectal cancer mouse xenograft model. Our presented approach can 17 
be in the future applied to study the effect of cytostatic, cytotoxic and anti-angiogenic 18 
chemotherapy and is ideally suited for translational systems biology, where rapid interaction 19 
between theory and experiment is essential. 20 
 21 
  22 
 Vascular tumour models studied by avascular elements 
 3  
Introduction 1 
Vascularisation of tumours is essential for their progression and, therefore, several therapeutic 2 
strategies seek to target tumour vessels [1-3]. As a consequence, studying how the structure 3 
and amount of vessel penetration give rise to differing tumour proliferation patterns is of 4 
theoretical [4, 5], diagnostic [6, 7] and therapeutic interest [8, 9]. For such studies, 5 
mathematical and computational approaches are often applied [7, 10-14]. However, most of 6 
the existing models confine themselves to the study of avascular tumour proliferation. In turn, 7 
when models consider the detailed impact of the vessel network and the resulting supply of 8 
nutrients and waste disposal, they become mathematically complex, require high 9 
computational resources and are challenged by the incorporation of complex experimental data. 10 
Hence, such models are often impractical for systems biology, where a rapid cycle of 11 
theoretical predictions and experimental findings is required to obtain new biological insight 12 
[15, 16]. 13 
A technically simple and elegant method to study the interaction of cells and their vascular 14 
environment are cellular automata [17, 18], which are often combined with differential 15 
equation approaches. As such, Patel and colleagues [19] implemented a numerically fast, 16 
partial differential equation-based approach to calculate the spatiotemporal distribution of 17 
nutrients such as oxygen, glucose and disposal of waste (lactate) dependent on the vascular 18 
supply. This approach was combined with a 2-dimensional cellular automata model to study 19 
the distribution of proliferating, quiescent and dead tumour cells and their dependence upon 20 
nutrient supply via blood vessels. However, the benefit of simplicity came at the cost of 21 
disregarding information about the vascular structure, which would require a computationally 22 
extensive 3-dimensional cellular automata approach such as the one presented by Welter [13, 23 
14].  24 
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The aim of our study was to construct a model that includes first principle biophysical 1 
constraints on cellular migration, nutrient consumption, cell proliferation and cell death. We 2 
therefore built upon the ideas of Patel [19] and the work of the Galinsky group [11, 12]. Instead 3 
of taking into account extended complex vessel structure of an entire tumour, however, we 4 
assumed the existence and interplay of small avascular volume elements (AVEs) that make-up 5 
the tumour. Amount of vascularisation and its grade of heterogeneity can then be taken into 6 
account by different distributions of AVEs with different sizes. The AVE size distribution can 7 
then be used to calculate the number of proliferating, quiescent and dead cells in the tumour. 8 
We subsequently used the model to identify, and mechanistically explore, diverse hypotheses 9 
that relate vessel density and distribution to amount of tumour cell proliferation. We finally 10 
experimentally illustrate the presence of these novel findings by a de novo mouse xenograft 11 
model.  12 
 13 
14 
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Results 1 
A model to study vascularised tumours via decomposition into avascular elements 2 
We pursued a pragmatic approach for studying vascular tumour proliferation that is suitable 3 
for rapid hypothesis testing. We assumed a certain vascular tumour tissue which we 4 
decomposed into avascular elements (AVEs; Fig 1A).  We modelled that these AVEs exchange 5 
nutrients such as glucose, oxygen, and lactate (waste), together with cells via adjacent AVEs 6 
not separated by vessels (Fig. 1B). We reasoned that the relative AVE size distribution contains 7 
sufficient information to characterise the density and heterogeneity of tumour vascularisation 8 
(Fig 1C, having 10 different AVE sizes). For mathematical and computational simplicity, 9 
AVE’s were assumed as half cylindrical volumes with height equalling their diameter and a 10 
vessel at its centre (Fig 1D). Using this decomposition, we have transformed the problem of 11 
vascular tumour proliferations to the interplay of multiple AVE of a simple geometry, allowing 12 
us to reuse modelling methods, previously applied to study avascular cell proliferation [10, 20, 13 
21]. Following these approaches, we studied the distribution of proliferating (P), quiescent (Q) 14 
and dead (D) cells within each AVE. We were interested in the relative composition of these 15 
cells within a given tissue rather than studying absolute tumour size. This was due to the fact 16 
that we regard a high proliferative index (the amount of proliferating cells per given tissue) as 17 
a means of tumour aggressiveness, leading to metastasis and relating to a worse prognosis [22-18 
24]. We considered changes in each tumour cell type by transition rates. These transition rates 19 
were made dependent on oxygen, glucose and lactate concentrations and amount of available 20 
space for cell proliferation (Fig 2AB, Supplementary Figure 1AB, Table 3 and methods). 21 
Exchange between AVE’s was integrated by allowing a net flow of nutrients, waste and cells 22 
between AVE’s of different size, accounting for inter AVE gradients. This exchange is 23 
indicated by the arrows in Fig 1B. Given that, in turn, this net flow was dependent on the actual 24 
nutrient and tumour cell concentrations of all AVEs, an iterative procedure was pursued to 25 
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solve the equations. The used workflow is shown in Fig 2C and described in detail in the 1 
method section. The entire procedure was repeated for each tissue with a given vasculature. 2 
 3 
Calculation of an exemplary AVE size distribution from a virtual tissue as model input 4 
The relative AVE size distribution is the model’s starting point. Such AVE size distribution 5 
can be obtained from 2D and 3D images of entire tissues by any classical tiling approach [18, 6 
25, 26]. For our subsequent calculations, we however opted for a simpler procedure. The 7 
detailed procedure is described in the methods and was used for the entire calculations. We 8 
thereby generated an artificial 2D tissue. In this tissue, we distributed points that represent 9 
vessel, assuming inter vessel distances (IVD) that were taken from histology of colorectal 10 
carcinomas [27]. We subsequently used an algorithm to calculate the distance for each point of 11 
this artificial tissue to the nearest vessel, giving us a histogram for AVE sizes. We specifically 12 
assumed an average inter vessel distance of 75 M, but with different heterogeneity in vascular 13 
structure (Fig 3AB). In the remainder of the manuscript we will refer to them as homogeneous 14 
and heterogeneous vasculature (Fig 3C, red and black bars).  15 
 16 
The model predicts increased cell proliferation and death upon higher vessel 17 
heterogeneity 18 
Having determined a distribution of AVE sizes that represent a homogenously and 19 
heterogeneously vascularised tissue with the same average IVD (Fig 3C), we then investigated 20 
the effect of the different amount of vascularisation on the distribution of proliferating, 21 
quiescent and dead cells. We found that, while a homogenous tissue leads to very little 22 
proliferation and only limited cell death, a heterogeneous distribution led to 12% cell death and 23 
10% proliferating cells (Fig 3D). To investigate this further, we looked at the distribution of P, 24 
Q, and D cells in AVEs of different types. In the homogenous tissue, we observed some cell 25 
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death in the larger AVEs 6-10 (Fig 3E), but this effect was greatly diminished once weighting 1 
over the volume distributions for AVES of the entire tissue (Fig 3F; bars equal to 100%). In 2 
contrast, looking at AVEs of a heterogeneous tissue, we found markedly more proliferation in 3 
the smallest AVE and more cell death in the larger ones (Fig 3G), such that the effect of 4 
proliferation and death was preserved when the contribution of each AVEs to the entire tissue 5 
was assessed (Fig 3H). Moreover, a small effect of proliferative compensation, whereby dead 6 
cells are replaced by nascent cells was observed in larger AVEs (small black area in Fig 3G) 7 
and also contributed slightly to the overall higher rate of proliferating cells in a heterogeneous 8 
tissue (Fig 3H). We conclude that a higher heterogeneous tissue leads to spatial areas with high 9 
cell proliferation and high cell death as a consequence of having rather small and rather large 10 
AVEs. In contrast, a homogenous tissue led to a high amount of quiescent cells due to a modest 11 
distribution of AVE sizes causing no significant compensatory proliferation of dead cells (see 12 
illustration in Supplementary Figure 1CD). 13 
 14 
Sensitivity analysis suggests stability of our model to AVE partition 15 
Due to the higher proliferation characteristics of the heterogeneous tissue, suggesting higher 16 
tumour aggressiveness, we focussed on this in the further analysis. As certain parameters had 17 
to be estimated in the model, we wanted to consider their influence on the cellular composition. 18 
We therefore increased or decreased each of these 12 parameter by 10% and calculated absolute 19 
changes in relative or absolute cell compositions (see Fig 4AB and Supplementary Figure 2AB, 20 
respectively). This sensitivity analysis revealed that vessel permeability (𝜗), oxygen 21 
consumption (𝑓𝑜𝑄) and the proliferation threshold for oxygen (co PT) were fairly influential 22 
factors. In addition, the robustness of the model was tested by increasing the number of AVEs, 23 
therefore representing finer grained AVE size distribution. This yielded a slight decrease of 24 
absolute cell numbers compared to the unchanged model (Supplementary Fig 2C), but, 25 
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otherwise, lead to almost the same cell compositions when the number of AVEs was increased 1 
(Fig. 4C).  2 
 3 
Model calculation for different IVDs suggests that cell proliferation may increase when 4 
vascularisation decreases  5 
We next investigated the change of cell composition for different vessel densities. We therefore 6 
repeated our calculation of the AVE distribution from a virtual tissue using the method 7 
described before (Fig 3AB) and using a different average IVD as basis. As expected, 8 
calculating the amount of proliferating, quiescent and dead cells, we found that that the amount 9 
of total cells decreased with decreased vessel density (increased IVD), suggesting that under a 10 
very low vessel density, the tumour cannot sustain a large number of cells (Fig 5A). This 11 
decrease was matched by a decrease of quiescent cells. However, when analysing the amount 12 
of proliferating and dead cells, we found that their amounts were increasing with increasing 13 
IVD until a peak was reached around an average IVD~80, followed by a subsequent decrease 14 
at higher IVDs. Looking at the predicted oxygen and glucose levels (Fig 5BC), this surprising 15 
results could be explained by a trade-off between two effects. Firstly, at low IVDs, tissue 16 
nutrient perfusion was high, and hence amount of cell death and compensatory proliferation 17 
was low. When tissue becomes less vascularised, cells started to die, while enough supply was 18 
available to allow for compensatory proliferation. At higher IVD, however, oxygen levels fell 19 
under the threshold that is necessary for cell proliferation (Fig 5B small dashed line), leading 20 
to decreased proliferation and contributing to a further decrease in overall cell numbers. 21 
However, oxygen levels remained high enough to sustain cellular survival (Fig 5B, dotted line) 22 
and therefore cell death continued to decrease as consequence of the decrease in total amount 23 
of cells. Finally, cellular glucose levels dropped while lactate levels increased when the average 24 
IVD was increased (Fig 5CD). All entities, oxygen, glucose and lactate, eventually reached a 25 
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constant value. This constant value was established since not only nutrient perfusion of the 1 
tissue, but also nutrient consumption (due to a lower amount of cells) decreased when IVD 2 
increased. We further note that the calculated oxygen and glucose levels were consistent with 3 
physiological values [28-30] and experimental data of 0.08 mM and 5.5 mM as determined by 4 
[31]. In addition, we remark that values of oxygen, glucose and lactate at low vessel densities 5 
are consistent with those for mild hyperglycaemia, acidosis and hypoxia which are likely 6 
conditions in less perfused regions of the outer tumour rim.  7 
 8 
We then investigated the amount of proliferation and cell death in regions close to the 9 
proliferation peak. We therefore selected two average IVD values, IVD = 64 and IVD= 85 and 10 
re-used the method of Fig 3AB to calculate vessel distributions associated to each IVD. We 11 
then calculated the amount of proliferating and dead cells. We observed an increase in cell 12 
proliferation of 38% and cell death of 31% (Fig 5E) when the average IVD was increased from 13 
64 to 85. Analysing the relative contribution from each AVE between both distributions, we 14 
found that the increased proliferation was observed mainly in the smallest AVE. In contrast, 15 
the amount of dead cells was found in medium and larger AVE, together with a small 16 
concomitant increase in compensatory proliferation (Fig 5FG). We note that the assumption of 17 
a 37% increase in the average IVD between IVD = 64 and IVD= 85 (which is around the 18 
published value of IVD =75) [27] will be useful in the subsequent experimental analysis. 19 
 20 
Decrease of micro vessel density is linked to increased tumour proliferation in 21 
subcutaneous HCT116-luc2 tumour  22 
Our modelling results provided evidence that an increased proliferation can be present even 23 
under decreased vascularisation (i.e. increased IVD) within certain vascularisation regimes. 24 
We therefore were interested if we could illustrate this relation by an experimental case. To do 25 
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so, we required a model system for rapid hypothesis testing where the same type of tumour 1 
was analyses under a different amount of vascularisation. We  hence used a mouse xenograft 2 
model established in our laboratory  [32] where human HCT116-luc2 colon cancer cell lines 3 
were subcutaneously (SubQ) implanted into Balb/c nude mice.  We sacrificed mice at day 8 (n 4 
= 2) and day 18 (n = 2) post-implantation and analysed tumours histologically in 10 5 
independent fields of the outer tumour rim from 2 mice at each time point.  6 
We first used IHC staining with PECAM1/CD31 antibody to determine the microvessel density 7 
(MVD) which is an experimental measure of the level of vascularisation and which has an 8 
inverse relationship to the IVD we used in the model. We observed a significant (p = 0.006) 9 
decrease in MVD of about 27 % from 22.4 ± 2.4 (day 8) to 16.3 ± 2.0 (day 18) (Fig. 6 A-C).  10 
The observed decrease in MVD in our SubQ model may be the result of increased 11 
biomechanical forces and vessel instability from day 8 to 18 as suggested by theoretical studies 12 
[33]. However, we were not interested in rigorously further pursuing this effect, but aimed to 13 
check the emergent consequence of this MVD decrease on the amount of proliferating and 14 
necrotic cells. We note that this decrease in MVD of 27% between day 8 and day 18 translates 15 
to an increase of IVD of 37% such as the one from IVD=64 (day 8) to IVD=85 (day 18) as 16 
assumed by Fig 5. 17 
We therefore repeated the analysis on the same tumours using KI67 staining for proliferating 18 
cells and TUNEL staining of cells dead by apoptosis, which is the predominant type of cell 19 
death in the outer rim region. Interestingly, despite decreased MVD, we identified a significant 20 
(p = 0.0006) increase in cell proliferation from 19.7 ± 1.7 % (day 8) to 28.3 ± 1.6 % (day 18) 21 
(Fig 6 D-F). This 44% increase in proliferation was a bit higher than model predictions of 22 
increased proliferation of 38% that was calculated from our model when IVD was increased 23 
from IVD=64 to IVD=85. Likewise, TUNEL apoptosis staining from ten independent fields of 24 
the same tumours revealed a non-significant (p = 0.098) increase of number of TUNEL-25 
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positive cells per field of view from 5.8 ± 0.7 (day 8) to 8.0 ± 0.8 (day 18), reflecting an 38% 1 
increase that coincides with a model prediction of a 31% increase (Fig. 6 G-I).  2 
3 
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Discussion 1 
In this study, we developed a method to investigate how complexity and amount of vessel 2 
structures is correlated with tumour cell proliferation and death within a tissue. The benefit of 3 
this approach lies in its easy integration of experimental data, numerical speed and in the fact 4 
that neither large scale geometric information nor sophisticated numerical calculations are 5 
needed, allowing for a rapid cycle between theoretical predictions and preclinical validations. 6 
The input to our approach are size distributions of avascular elements (AVE’s) that give 7 
abstract information about vessel density and grade of heterogeneity at certain time points of 8 
the tumour. We wish to highlight here that our approach is therefore independent of the way 9 
these distributions are calculated. Here, we generated an AVE size distribution by applying a 10 
simple tiling method using stochastic seeding of test points and investigated the distance to the 11 
nearest vessels. For this specific method we assumed vessel distribution along a simulated 2D 12 
tissue. Hence, we did not take into account physiological branching structures, whereby larger 13 
vessels branch successively into smaller ones in a tree-like fashion to guarantee optimal 14 
nutrient support [34]. Therefore, any method to calculate AVE size distributions from realistic 15 
vascular tumours would require more sophisticated approaches in a 3D space [25, 26] such as 16 
Voronoi tessellation [18]. Nevertheless, such a physiologically homogenous vessel branching 17 
would also be expected to have a lower dispersion of AVE volume sizes than a heterogeneous 18 
one [35], exactly such as in our approach.  19 
The developed model predicts that tumours with a heterogeneous vessel distribution exhibit 20 
higher proliferation and more cell death compared to tumours with equal vessel densities and 21 
a more homogeneous vessel distribution. This is due to a higher spread of the AVE size 22 
distribution for tissues with higher heterogeneity resulting in areas with a high nutrient supply, 23 
and thus greater proliferation, but also areas with low nutrient supply and cell death. Our 24 
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predictions are consistent with experimental findings from mouse mammary xenografts where 1 
tumour cell proliferation was mainly observed close to areas surrounded by vessels [36]. 2 
Because of their higher cell turnover (more cell death and consequent higher compensatory 3 
proliferation), tumours of heterogeneous tissues may thus have higher mutation rates, better 4 
genetic adaptation and higher aggressiveness. It is therefore tempting to speculate that by 5 
reducing heterogeneity as done by VEGF-inhibitors such as Avastin, mutational rates may be 6 
lowered in highly heterogeneously vascularised tumours and, hence, malignancy may be 7 
mitigated or tumours may be more amenable to standard treatments [37-39]. 8 
 9 
Using the gold-standard HCT-116-SQ mouse xenograft, we have observed a decrease in MVD 10 
of tumours in the colorectal cancer model employed. While this result warrants a more rigorous 11 
investigation, a similar finding has been observed previously by Hemmerlein 2001 et al [40]. 12 
It was, however, not our aim to investigate vascularisation kinetics during tumour growth or 13 
even compare our mouse model to others, as this would have required a larger scale 14 
investigation. For our approach this change in MVD was a convenient choice to study the 15 
effects of changed microvessel density on the cell proliferation in a tumour.  16 
 17 
Our modelling approach qualitatively reflected the trend of our mouse model that vessel density 18 
negatively correlates with tumour proliferation under some regimes of vascularisation. The 19 
effect was explained by a trade-off between increase in compensatory proliferation for 20 
replacing dead cells and a decrease of cell population due to lack of oxygen when nutrient 21 
perfusion gets low. Our combined model and experimental efforts therefore suggest that the 22 
apparently trivial relationship between increased vascularisation and proliferation does not 23 
necessarily hold for all situations. Consistent with our findings, Lee and co-workers found an 24 
inverse correlation between microvessel density and numbers of apoptotic cells in mammary 25 
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ductal carcinoma. They further reported an inconclusive relationship between microvessel 1 
density and proliferation [9], disputing the notion that vascularisation is intrinsically linked to 2 
higher proliferation in all vascularisation regimens. Besides these qualitative predictions, we 3 
predicted quantitative changes of oxygen, glucose and lactate during changes of the IVD which 4 
can be validated in follow-on experimental studies. Specifically, we note that our values of 50-5 
150 nmol/cm3 oxygen (0.05-0.15 mM), 3-4.5 mol/cm3 glucose (3-4.5 mM) and 1-2.4 6 
mol/cm3 (1-2.4 mM) of lactate are in excellent agreement with physiological levels of glucose 7 
2-5 mM and lactate (0.5-2.2 mM; [28]) in blood and with oxygen and glucose levels from Jiang 8 
et al [31] of 0.08 mM and 5.5 mM.  9 
 10 
   11 
The validity of our model is confined to studying the proliferation characteristics in the outer 12 
rim of the tumour. Specifically, we neglected the necrotic core which is the most decisive factor 13 
for tumour expansion. Taking into account the necrotic core would have resulted in 14 
discontinuous AVE size distribution with the necrotic core as one large AVE that is connected 15 
to several smaller ones. This would have violated our assumption that all AVEs are 16 
continuously distributed and connected with each other in an equal manner. Moreover, the high 17 
space demand in the tumour core would require us to take into considerations high 18 
biomechanical forces which would be at odds with our model of free nutrient diffusion and the 19 
simple convective-diffusive transport of cells (Equations 4-5). Therefore, instead on focussing 20 
on tumour expansion, we rather investigated the proliferative index of a given tissue. Indeed, 21 
the KI67 proliferative index is positively correlating with tumour grade, metastasis and worse 22 
prognosis in solid tumours [22-24], rendering the fact that cancer dead is more related to the 23 
propensity of metastasis than with growth of the primary tumour [41, 42]. Likewise, Vartian 24 
and Weidner observed that KI67 staining in the tumour cores of samples from patients with 25 
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breast carcinomas was 45-fold greater than in adjacent tissue [7], demonstrating the relevance 1 
of this parameter for tumour progression 2 
 3 
Other models have been developed to study the effects of vascularisation using cellular 4 
automata [13, 19, 43, 44], stochastic differential equations [45] or multiphase model 5 
approaches [46, 47]. Even if they were experimentally validated, such models are often 6 
restricted to the study of tumour spheroids and not applied to the study of vascularised tumours 7 
[10, 21]. Indeed, approaches using cellular automata easily become computationally complex 8 
and cannot be applied for studying larger tumours. In contrast, our presented model can be 9 
studied with the same mathematical and numerical formalism for tumours of different sizes. 10 
As our tiling method for studying AVEs may require finer granularity for larger and more 11 
heavily vascularised tumours, restrictions in tumour size may only apply indirectly. 12 
Nevertheless, the computational effort of our algorithm scales with linear power in the number 13 
of different vascular elements N for the equations 1-3 and has only quadratic dependency on 14 
the amount in the exchange term equation 4-9, which for the current calculation consumed less 15 
than 10 % of calculation time. This may become prominent for higher values of numbers of 16 
AVEs. In contrast, Cellular Automata approaches scale with the cubic power of the number of 17 
grids used per tumour length. This together with the smaller numbers of AVEs compared to 18 
the amount of grids gives our approach an advantage over 2D and especially 3D Cellular 19 
Automata approaches with respect to numerical costs. 20 
 21 
In conclusion, the model concededly has its limitations. Firstly, as the model cannot account 22 
for studying growth of the necrotic core, it cannot be used to assess the size of the tumour, but 23 
focuses rather on studying a proliferative index dependent on amount and type of 24 
vascularisation. Secondly, we modelled only tumour cells and not tumour stromal cells. Hence, 25 
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the formalism shall be adapted when other regions than the proliferative tumour rim are 1 
modelled such as adjacent adipose tissue which would have other metabolic and proliferative 2 
rates. We further only provided a qualitative estimation of cell and nutrient exchange terms 3 
(Eq. 4 and 5) and this formalisms may be further improved once a theory of convection and 4 
diffusion of cells and nutrients is available. We finally mostly refrained from going into 5 
predictions on a too quantitative level. We rather used the model as a tool to assess potential 6 
relevant qualitative effects that arise during tumour proliferation as consequence of different 7 
amounts and different heterogeneity of vascularisation. Indeed, we are not entirely sure that all 8 
parameters to remodel a quantitative proliferative response are experimentally known and 9 
controlled, and hence only focussed on those experimental parameters that are currently widely 10 
accepted to control tumour proliferation. Despite these drawbacks, we provide here a pragmatic 11 
model that includes first principle biophysical constraints. With this concept, we were able to 12 
tackle the complex problem of vascular tumour proliferation by decomposing the tissue into 13 
avascular elements, allowing us to reuse concepts from modelling spheroids. We preferred this 14 
first-principle, qualitative approach over a merely fitting exercise where parameters are adapted 15 
to correct for the inevitable model abstractions of a highly simplified model. We demonstrated 16 
that this model concept can serve as a template for analysis of experimental tumour models and 17 
that it was even possible to render trends of cell proliferation and cell death under altered 18 
vasculature. We present this approach to the readers of JTB for further elaboration by the 19 
biophysical community in follow on studies. In the future, our approach can be extended to 20 
integrate mechanisms of tumour vessel development [25, 26] or to include the effect of 21 
cytotoxic and cytostatic chemotherapy, which could be simply implemented by making the cell 22 
transition rates of Fig. 2B dependent on drug action. Likewise, it would allow the study of anti-23 
angiogenic drugs by modelling their impact on tumour vasculature and exploiting the model to 24 
assess changes in tumour cell composition. 25 
26 
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Methods 1 
Ethics statements 2 
All animal experiments were performed by licensed investigators in accordance with animal 3 
research guidelines (Department of Health and Children, Dublin, Ireland) and protocols were 4 
approved by the Animal Research Ethics Committee at University College Dublin, where the 5 
work was performed. Animals were housed in groups, maintained on a 12 hour light/dark cycle, 6 
with access to food and water ad libitum.  7 
Modelling vascularised tumours by decomposition into avascular elements 8 
A semi-phenomenological approach was chosen to account for the influence of the vascular 9 
system. Thereby, the vascular system was assumed to serve as source and drain for nutrient 10 
and waste and thereby affect tumour proliferation [11]. To facilitate calculation of nutrient 11 
supply and waste removal, the complex 3-dimensional vessel structures was replaced assuming 12 
the tissue to be composed of avascular elements (AVEs). An illustration of the concept is given 13 
in Fig. 1A-B. AVE volumes with the characteristic radius 𝑅𝐴𝑉𝐸 and their relative fractions were 14 
estimated by the following procedure. AVEs were assumed to have a geometry that is 15 
simplified to half cylinders whose height equalled their diameter. A vessel with a constant 16 
radius was assumed to be located at the cylinder’s centre (Fig 1D). Due to this approximation 17 
cylindrical coordinates and periodic boundary condition (Table 5) could be used, allowing for 18 
a simplified (i.e., one dimensional) calculation of nutrient and cell profiles within the AVE 19 
volume. The relative fraction of AVEs of different sizes, (i.e., the AVE size distribution), 20 
represents the underlying vessel structure such as vessel density and regularity. The AVEs were 21 
assumed to be connected with each other to allow the exchange of cells, nutrients, and waste. 22 
Mathematically, this exchange was incorporated with the aid of the exchange source terms in 23 
the PDEs as described below. Boundary conditions according to Table 4 were assumed to 24 
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model transport of nutrients/waste out of/into blood vessels. The transport dynamics was made 1 
dependent on the concentration gradient at the vessel wall and its selective permeability as in 2 
[19]. Migration of cells between the vessel and the tumour was disregarded. 3 
 4 
Quantification of relative occurrence of avascular elements 5 
To obtain an AVE size distribution from intervessel distances (IVD), we created a 2D virtual 6 
tissue whereby we spotted virtual vessels with the given IVD (=75 µm) and with a vessel 7 
diameter (𝑟𝑣𝑒𝑠𝑠𝑒𝑙 = 1.94 m) that reflected previously published data (Fig. 3AB) [27]. To 8 
generate homogeneously and heterogeneously virtual tissues of the same vessel density, spots 9 
(representing the vessels) were equidistantly distributed for both tissue types. In the case of the 10 
heterogeneous tissue, twice as many spots were placed initially and half of them were removed 11 
arbitrarily to create an irregular pattern. In order to obtain the AVE size distribution that 12 
represents a tissue, 10 000 test points were randomly placed into the virtual tissues. Afterwards, 13 
distance distributions of these points from the two nearest vessels were determined (𝑟𝑣1, 𝑟𝑣2), 14 
and the characteristic length of an AVE was defined by 𝑅𝐴𝑉𝐸  =  ½ ∙ (𝑟𝑣1 +  𝑟𝑣2). AVEs were 15 
binned into 10 equally spaced containers according their characteristic radii 𝑅𝐴𝑉𝐸  (𝑅𝐴𝑉𝐸  =16 
[𝑅𝐴𝑉𝐸 𝑚𝑖𝑛, … , 𝑅𝐴𝑉𝐸 𝑖, … , 𝑅𝐴𝑉𝐸 𝑚𝑎𝑥]; 𝑅𝐴𝑉𝐸 𝑚𝑖𝑛 = 76 m, 𝑅𝐴𝑉𝐸 𝑚𝑎𝑥 = 103 m for homogenous 17 
and 𝑅𝐴𝑉𝐸 𝑚𝑖𝑛 = 61 m, 𝑅𝐴𝑉𝐸 𝑚𝑎𝑥 = 204 m for heterogeneous tissue) leading to a histogram of 18 
relative occurrence 𝜔𝑖, hist 𝑅𝐴𝑉𝐸  :=  𝝎 = [𝜔1, … , 𝜔𝑖, … , 𝜔10].  19 
Finally, to account for the fact that randomly placed points have a greater likelihood to be 20 
counted by this procedure due to their larger area [48], the probability distribution of the 21 
recorded histogram 𝜔(Xω) was weighted by the AVE cross section 𝐀𝛚 =22 
[Amin, … , Ai, … , Amax] with Ai = 𝑅𝐴𝑉𝐸 𝑖 
2  +  𝑟𝑣𝑒𝑠𝑠𝑒𝑙
2. The relative occurrence of AVEs in the 23 
tissue 𝝎(RAVE) is plotted in Fig 3C, whereby homogenously and heterogeneously vessel 24 
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distribution differed in the spread of the covered range of characteristic radii. From the 1 
characteristic radii, AVE volumes were created according to the formula of half cylinders with 2 
same height as diameter Voli =𝜋 ∙ (𝑅𝐴𝑉𝐸 𝑖 
2 − 𝑟𝑣𝑒𝑠𝑠𝑒𝑙
2) ∙ 2 ∙  𝑅𝐴𝑉𝐸  . The volume distribution is 3 
hence characterised by those from the corresponding radii with an x-axis that scales with the 4 
third order of the radii.  5 
As mentioned above the vessel homogeneity in this paper denotes an average distribution of 6 
vessels in two dimensions, and not a physiologically observed 3-dimensional tree-based vessel 7 
structure. 8 
Dynamic equations of oxygen, glucose, waste and tumour cell types within AVEs 9 
To calculate the dynamics of nutrients, waste and tumour cells within a particular AVE, a 10 
framework as frequently applied to tumour spheroids was followed. Therefore, tumour 11 
proliferation profiles within each AVE were calculated by determining spatiotemporal profiles 12 
of different tumour cell types. Consistent with approaches in [49, 50] the number of pro-13 
liferating (P), quiescent (Q) and dead (D) cells (as a collective term for all types of cell death) 14 
per volume unit was assumed. Their evolution was influenced and in turn influences the 15 
availability of glucose (g), oxygen (o) and waste (w, lactate within this work).  16 
Oxygen, glucose, and waste were assumed to penetrate via the vessels walls. While oxygen 17 
and glucose are consumed, waste is produced by proliferating or quiescent tumour cells (P, Q). 18 
The temporal (time t) and spatial (radius of the AVE r) evolution of their concentration co (r,t), 19 
cg (r,t) and cw (r,t) within each AVE is given by the following-reaction diffusion equations:  20 
 21 
𝜕𝑐𝑜
𝜕𝑡
= ∇ ∙ (𝐷𝑜 ∙ ∇𝑐𝑜) + 𝑓𝑜(𝑃, 𝑄, 𝑁)  
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𝜕𝑐𝑔
𝜕𝑡
= ∇ ∙ (𝐷𝑔 ∙ ∇𝑐𝑔) + 𝑓𝑔(𝑃, 𝑄, 𝑁)  
𝜕𝑐𝑤
𝜕𝑡
= ∇ ∙ (𝐷𝑤 ∙ ∇𝑐𝑤) + 𝑓𝑤(𝑃, 𝑄, 𝑁) 
 
Equation 1 
In the partial differential equations (PDEs) in Equation 1 the first term on the right hand side 1 
describes the diffusion of oxygen, glucose and waste with respective diffusion constants 2 
𝐷𝑂, 𝐷𝐺 , 𝐷𝑊, assuming that these entities diffuse homogenously through the entire tissue. The 3 
entities 𝑓𝑜, 𝑓𝑔, 𝑓𝑤 denote the source terms that account for change of oxygen, glucose or waste 4 
by their turnover (consumption or production) and the diffusive exchange of oxygen, glucose 5 
or waste among AVEs (via exchange terms as described later).  6 
The source terms of Eq. 1 were modelled by 7 
𝑓𝑜 = 𝑃 𝑓𝑜𝑃 +  𝑄 𝑓𝑜𝑄 + 𝐴𝑉𝐸𝑒𝑥 𝑜  
𝑓𝑔 = 𝑃 𝑓𝑔𝑃 +  𝑄 𝑓𝑔𝑄 + 𝐴𝑉𝐸𝑒𝑥 𝑔  
𝑓𝑤 = 𝑃 𝑓𝑤𝑃 +  𝑄 𝑓𝑤𝑄 + 𝐴𝑉𝐸𝑒𝑥 𝑤  
 
 
Equation 2 
whereby oxygen and glucose were consumed by proliferating P (with rate per cell of 𝑓𝑜𝑃 and 8 
𝑓𝑔𝑃 ,, respectively; Table 1) and quiescent cells Q (with rate per cell of 𝑓𝑜𝑄 and 𝑓𝑔𝑄; Table 1). 9 
Likewise, 𝑓𝑤𝑃 and 𝑓𝑤𝑄 were the rate of waste production by proliferating and quiescent cells, 10 
respectively. The terms 𝐴𝑉𝐸𝑒𝑥 𝑜 , 𝐴𝑉𝐸𝑒𝑥 𝑔 , 𝐴𝑉𝐸𝑒𝑥 𝑤  were denoted in this paper as AVE 11 
exchange source terms and account for the exchange between AVEs of different size as 12 
subsequently described.  13 
The spatiotemporal concentration of all cell types (P(r,t), Q(r,t), D(r,t)) was modelled by 14 
 15 
𝜕𝑃
𝜕𝑡
= 𝛻 ∙ (𝐷𝑃 𝛻𝑃) + 𝐾𝐵 𝑃 − 𝐾𝑄(𝑐) 𝑃+𝐾𝑃(𝑐) 𝑄 + 𝐴𝑉𝐸𝑒𝑥 𝑃 
𝜕𝑄
𝜕𝑡
= 𝛻 ∙ (𝐷𝑄  𝛻𝑄) + 𝐾𝑄(𝑐) 𝑃−𝐾𝑃(𝑐) 𝑄−𝐾𝐷(𝑐) 𝑄 + 𝐴𝑉𝐸𝑒𝑥 𝑄 
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𝜕𝐷
𝜕𝑡
= 𝛻 ∙ (𝐷𝑁 𝛻𝐷) + 𝐾𝐷(𝑐) 𝑄 − 𝐾𝑅 𝐷 + 𝐴𝑉𝐸𝑒𝑥 𝐷 
Equation 3 
with c denoting the dependency of above parameters on oxygen, glucose and waste 1 
concentration as described below. As before, all cell types were modelled to diffuse within the 2 
extracellular matrix as given in the first term on the right hand side of each equation and 3 
characterised by the effective diffusion constants Dp, Dq and Dd. These diffusion constants were 4 
modelled to depend on the total cell density (𝑐𝑑 = 𝑃 + 𝑄 + 𝐷) to account for diffusion 5 
impairment due to increased cell crowding following the approach of Gatenby [11, 12]. Here, 6 
the density-dependent effective diffusion coefficients were defined as 𝐷𝑃 = 𝐷𝑝 𝑎,  𝐷𝑄 =7 
𝐷𝑞 𝑎,  𝐷𝐷 = 𝐷𝑑  𝑎 𝐷𝑃 = 𝐷𝑝 𝑎,  𝐷𝑄 = 𝐷𝑞 𝑎,  𝐷𝐷 = 𝐷𝑑  𝑎. We thereby set 𝑎 = exp (
−5 𝑐𝑑
𝑐𝑑𝑚𝑎𝑥
 ) 𝑐𝑑𝑚𝑎𝑥 8 
to obtain a stable decaying function with cell density cd and used the constant 5 to have 9 
diffusion sufficiently blocked at maximum cell densities 𝑐𝑑𝑚𝑎𝑥 (<1% of max). 10 
Further terms at the right hand side of Equation 3 characterise the transition of cells between 11 
of different types (P, Q, D) as illustrated in Fig. 3A. For these terms in Equation 3 the transition 12 
parameter 𝐾𝐵 denotes the rate of cell birth, 𝐾𝑄 the rate at which proliferating cells become 13 
quiescent, 𝐾𝑃 the rate at which quiescent cells become proliferating, 𝐾𝐷 the rate of quiescent 14 
cells dead and 𝐾𝑅 accounts for the disintegration and removal of dead cells which was assumed 15 
to be 𝐾𝑅 = 𝐾𝑟 ∙ exp(−100 ∙ 𝑅𝐴𝑉𝐸  ). The factor 100 cm
-1 was assumed to allow for a moderate 16 
dependency with AVE size (as 𝑅𝐴𝑉𝐸 was given in cm for our calculations, therefore the 17 
exponential factor varied around 1 for a typical AVE). The factor Kr (Table 1) was assumed to 18 
reflect a half time of degradation of 1.5 h which was considered as the typical time for 19 
phagocyting dead cells. 𝐾𝑃, 𝐾𝑄, and 𝐾𝐷 are described below. 𝐾𝐵, was constant while 𝐾𝑅 was 20 
made dependent on the AVE size to account for slower removal rates and response times (e.g. 21 
due to macrophages clearing the cellular debris) in the case of bigger AVEs.  22 
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 1 
Transition rates between tumour cells and their dependency on nutrients, waste and cell 2 
density 3 
According to a procedure as given in [49, 50], tumour cells of different kinds were assumed to 4 
change their state as given in Fig 2. The respective transition rates for cell proliferation 𝐾𝑃, for 5 
proliferating cells becoming quiescent 𝐾𝑄 and for quiescent cells to die 𝐾𝐷 were modelled to 6 
be dependent on the cell density, and the concentration of oxygen, glucose and waste. Three 7 
different types of thresholds for oxygen, glucose and waste levels were introduced to 8 
incorporate the combinatorial effect of different nutrient/waste concentrations (see Table 1) on 9 
cell transition. These were the survival thresholds (𝑐𝑜𝑇,𝑐𝑔𝑇,𝑐𝑤𝑇 ), proliferation thresholds 10 
(𝑐𝑜𝑃𝑇,𝑐𝑔𝑃𝑇,𝑐𝑤𝑃𝑇 ) and a threshold for optimal conditions (𝑐𝑜𝑜𝑝𝑡,𝑐𝑔𝑜𝑝𝑡,𝑐𝑤𝑜𝑝𝑡 ). For the making the 11 
transition rates dependent on nutrient and waste distribution (i.e.,  𝑐𝑜 , 𝑐𝑔 and 𝑐𝑤), three specific 12 
conditions, denoted here as limit conditions, were assumed as follows:  13 
 14 
Rates under condition of cell death: Whenever either oxygen or glucose supply was assumed 15 
to fall below (𝑐𝑜 < 𝑐𝑜𝑇 ;  𝑐𝑔 < 𝑐𝑔𝑇 ), or waste was to exceed (𝑐𝑤 > 𝑐𝑤𝑇 ), the respective survival 16 
thresholds, proliferating cells were assumed to become quiescent and quiescent cells were 17 
assumed to die (KP = 0,  KQ > 0, KD > 0). The following rules for transition rates at the 18 
different thresholds apply: 19 
 20 
Rates at the proliferation threshold: Whenever oxygen and glucose were exceeding the 21 
respective proliferation thresholds (𝑐𝑜 > 𝑐𝑜𝑃𝑇 ;  𝑐𝑔 > 𝑐𝑔𝑃𝑇 ), and the waste level was 22 
undergoing the latter (𝑐𝑤 < 𝑐𝑤𝑃𝑇 ), quiescent cells were modelled to become proliferating 23 
(𝐾𝑃 > 0) and the rate of cell death was assumed to be zero  (𝐾𝐷 = 0). 24 
 25 
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Rates at and above the threshold for optimal proliferation: When, at the same time, oxygen 1 
and glucose concentration were above and waste concentration below the threshold for optimal 2 
conditions (𝑐𝑜≥ 𝑐𝑜𝑜𝑝𝑡 , 𝑐𝑔≥ 𝑐𝑔𝑜𝑝𝑡 ,  𝑐𝑤 ≤ 𝑐𝑤𝑜𝑝𝑡 ), proliferation was maximum and rates for cells 3 
becoming quiescent or dead were zero (𝐾𝑃 = 𝐾𝑝, 𝐾𝑄 = 0, 𝐾𝐷 = 0).  4 
 5 
These limit conditions for cell transition rates are summarized in Table 2. Values for 𝐾𝑃, 𝐾𝑄, 𝐾𝐷 6 
between these limit conditions were interpolated via steady, differentiable, and monotonous 7 
functions of these transition rates for the entire range of glucose, oxygen and waste 8 
concentration. Therefore, cosine and sine functions scaled to the descending and ascending 9 
quadrant were chosen to have everywhere differentiable function that reflect the monotonous 10 
dependency of transition rates on the concentrations of nutrients and lactates  (Table 3). 11 
Supplementary Figure 1AB depict how 𝐾𝑃 and 𝐾𝑄 depend on oxygen and glucose.  12 
Furthermore, we assumed cell transition rates to be dependent on the cell density. Cell 13 
proliferation was only possible if the cell density 𝑐𝑑 was below the maximum density 𝑐𝑑 𝑚𝑎𝑥 =14 
5 ∙ 108 [cells cm3⁄ ] according to [12]. This value is in good agreement with those obtained for 15 
EMT6/Ro tumour spheroids (𝑐𝑑 = 3 − 5 ∙ 108  [cells cm3⁄ ]; [51]). To avoid that continuous 16 
cell proliferation could lead to cell densities higher than maximum value 𝑐𝑑 𝑚𝑎𝑥, the transition 17 
rate KP was made to decrease and KQ to increase with increasing cell densities (𝑐𝑑 → 𝑐𝑑 𝑚𝑎𝑥) 18 
as described in Table 4. Likewise, the factor in KQ in Table 4 was chosen to restrict the total 19 
amount of cells to 𝑐𝑑 𝑚𝑎𝑥 . 20 
Calculation of the AVE exchange source terms 𝐀𝐕𝐄𝐞𝐱   21 
AVE’s of different sizes were assumed to be connected to each other (and are not fully 22 
separated by the vessel network). Therefore, cells, nutrients and waste were assumed to 23 
exchange among AVE’s of different volumes. Consequently, disequilibrium in cells, nutrients 24 
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and waste results in a net flow of the latter between adjacent AVEs. We assumed that all AVEs 1 
were connected equally with each other, according to their relative occurrence 𝝎(RAVE). This 2 
net flow was introduced in Equation 2-3 and denoted as exchange source terms 𝐴𝑉𝐸𝑒𝑥.  3 
Within the following we describe how the exchange source terms for oxygen and for 4 
proliferating cells ( 𝐴𝑉𝐸𝑒𝑥 𝑜 and  𝐴𝑉𝐸𝑒𝑥 𝑃, respectively) were calculated at each iteration step, 5 
assuming above average nutrient, waste or cell concentrations to be known. Calculations of 6 
source term corrections for glucose (𝐴𝑉𝐸𝑒𝑥 𝑔  ) and waste (𝐴𝑉𝐸𝑒𝑥 𝑤  ) and other cell types 7 
( 𝐴𝑉𝐸𝑒𝑥 𝑄 ,  𝐴𝑉𝐸𝑒𝑥 𝐷) follow the same scheme. These exchange terms were assumed to be 8 
spatially independent. Therefore, the AVEex  terms could be considered to be constant over the 9 
entire distance of exchange which is the sum of the characteristic length RAVEi , RAVEj of 10 
adjacent AVEs. 11 
We first determine transfer rates for dissolved species such as nutrients and waste between 12 
AVEi and AVEj. We note that this exemplary choice of two AVEs does not require any specific 13 
spatial arrangements or other constraints, besides being of different size.  14 
As example we calculated the oxygen exchange rate 𝑎𝑣𝑒𝑒𝑥 𝑜 which was assumed to be dependent 15 
on the gradient between the average concentrations in the AVE (𝑐𝑜 𝐴𝑉𝐸𝑖 , 𝑐𝑜 𝐴𝑉𝐸𝑗) as 16 
𝑎𝑣𝑒𝑒𝑥 𝑜 =    𝐷𝑜 ∙
𝑐𝑜 𝐴𝑉𝐸𝑖 − 𝑐𝑜 𝐴𝑉𝐸𝑗
(𝑅𝐴𝑉𝐸 𝑖 + 𝑅𝐴𝑉𝐸 𝑗)
2 . 
Equation 4 
 17 
Equation 4 describes diffusive transport which is based on a flux rate according to Fick’s law 18 
of diffusion. The law assumes particles to move through a virtual area perpendicular to the 19 
diffusion direction and, hence, this flux is inversely proportional to the area spanned by the 20 
radii of both AVEs ([52], Supplementary Text 1). 21 
 22 
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In contrast to nutrients and waste where diffusion is quick and dominates the transfer, the 1 
calculation of cellular transfer rates such as proliferating cells (𝑎𝑣𝑒𝑒𝑥 𝑃) has also to account for 2 
convective transport. This convection is driven by different cellular occupancies leading to 3 
differential space restrictions and consequent pressure equilibration between AVEs. This 4 
generates a diffusion independent convective net flow that is dependent on the difference of 5 
cell densities in each AVEs (𝑐𝑑 𝐴𝑉𝐸𝑖), but independent of the actual cell type (i.e. not driven by 6 
entropy). Consequently, we combined the diffusion term, here shown for proliferating cells, 7 
with a convective term (on the right side of Eq. 5)  8 
𝑎𝑣𝑒𝑒𝑥 𝑃 =   𝐷𝑝 ∙
𝑃 𝐴𝑉𝐸𝑖−𝑃 𝐴𝑉𝐸𝑗
(𝑅𝐴𝑉𝐸𝑖+𝑅𝐴𝑉𝐸𝑗)
2  +  
104  
𝑐𝑑𝑚𝑎𝑥
∙
𝑐𝑑 𝐴𝑉𝐸𝑖 −𝑐𝑑 𝐴𝑉𝐸𝑗
(𝑅𝐴𝑉𝐸𝑖+𝑅𝐴𝑉𝐸𝑗)
2   . 
Equation 5 
We note that this represents a net flux that is analogous to the one of a convection-diffusion 9 
equation [53]. Thereby, the factor (
104 
𝑐𝑑𝑚𝑎𝑥
) of the second, convective term was adjusted to render 10 
cell occupancies for all AVEs which were assumed to vary only within a reasonable range of 11 
20% between the smallest (𝑉𝑜𝑙𝐴𝑉𝐸 𝑚𝑖𝑛 ) and biggest (𝑉𝑜𝑙𝐴𝑉𝐸 𝑚𝑎𝑥 ) AVE. We note that this term 12 
presents solely a heuristic expression for convective transport that is consistent with above 13 
biological assumptions as no current detailed theory of cell convection within tumours is 14 
available. 15 
Above transfer rates were subsequently used to calculate the temporal change (exemplified 16 
here for oxygen) in AVE 𝑖 and 𝑗 by weighting the exchange among AVEs according to their 17 
volumes to guarantee conservation of mass (i.e. cells or species) 18 
𝜕𝑐𝑜 𝐴𝑉𝐸 𝑖
𝜕𝑡
= − 𝑎𝑣𝑒𝑒𝑥  ∙ (
𝑉𝑜𝑙𝐴𝑉𝐸 𝑗 
𝑉𝑜𝑙𝐴𝑉𝐸 𝑗 + 𝑉𝑜𝑙𝐴𝑉𝐸 𝑖 
+ 0.5) 
𝜕𝑐𝑜 𝐴𝑉𝐸 𝑗
𝜕𝑡
= + 𝑎𝑣𝑒𝑒𝑥  ∙ (
𝑉𝑜𝑙𝐴𝑉𝐸 𝑖 
𝑉𝑜𝑙𝐴𝑉𝐸 𝑗 +𝑉𝑜𝑙𝐴𝑉𝐸 𝑖 
+ 0.5) . 
Equation 6 
By solving Equation 6, the net flow rates (here for oxygen) between two AVEs during a time 19 
step t can be determined as: 20 
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𝑐𝑜 𝐴𝑉𝐸𝑖,𝑗→𝐴𝑉𝐸𝑗,𝑖 =
(𝑐𝑜 𝐴𝑉𝐸𝑖,𝑗−𝑠𝑡𝑎𝑟𝑡−𝑐𝑜 𝐴𝑉𝐸𝑖,𝑗−𝑒𝑛𝑑)
∆𝑡
 , 
Equation 7 
whereby 𝑐𝑜 𝐴𝑉𝐸𝑖,𝑗−𝑠𝑡𝑎𝑟𝑡and 𝑐𝑜 𝐴𝑉𝐸𝑖,𝑗−𝑒𝑛𝑑 denote the oxygen concentrations at the beginning and 1 
end of a time step. Then, to capture the oxygen exchange between all AVE’s during a time 2 
step, we define the matrix  3 
  𝑴𝒄𝒐 𝑨𝑽𝑬 (𝑖, 𝑗) =     [
𝑐𝑜 𝐴𝑉𝐸1→𝐴𝑉𝐸1 = 0 ⋯ 𝑐𝑜 𝐴𝑉𝐸𝑗→𝐴𝑉𝐸1
⋮ ⋱ ⋮
𝑐𝑜 𝐴𝑉𝐸1→𝐴𝑉𝐸𝑗 ⋯ 𝑐𝑜 𝐴𝑉𝐸𝑖→𝐴𝑉𝐸𝑗=𝑖 = 0
] . 
Equation 8 
We further assumed that all AVEs are equally connected with each other. This assumption 4 
requires that AVE distributions are continuous (i.e. no single large AVE such a necrotic core). 5 
It further requires that the AVEs in any heterogeneous distribution would be rather statistically 6 
distributed within the tissue, while for homogenous distribution (having smaller differences of 7 
AVE sizes) the exchange term would have minor impact. 8 
Finally, the exchange source term of an AVE i (here for oxygen) was obtained by summing up 9 
the exchange with all AVE’s during a time step, weighted by the relative AVE 10 
occurrence 𝜔𝑖 (∑ 𝜔𝑖 = 1𝑖 ): 11 
    𝐴𝑉𝐸𝑒𝑥 𝑜  = ∑  𝜔𝑗  ∙
𝑁
𝑗=1 𝑴𝒄𝒐 𝑨𝑽𝑬 (𝑖, 𝑗)  , Equation 9 
Solution and numerical procedure for calculating proliferating, quiescent and death cells 12 
considering inter-AVE exchange 13 
The differential equations 1-3 that describe spatiotemporal cell distributions within the AVEs 14 
and the equations 4-9 that describe the exchange terms between AVEs form a self-consistent 15 
problem. This means that from spatial distributions of nutrients, waste and P, Q and D cells in 16 
each AVE (as calculated via Eq. 1-3), the AVE exchange terms have to be calculated according 17 
to Eq. 4-9. In turn, the exchange terms feed again into the differential equation 1-3, requiring 18 
the need for an iterative procedure.  19 
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The iteration was performed for a small, but finite time interval (∆t = 1 h ), for which we could 1 
assume the AVE exchange terms as constant. This assumption of constant AVE exchange 2 
terms allowed to decouple equation 1-3 from equation 4-9 in their time dependency, facilitating 3 
the numerical solution. The iteration at a certain time step was continued till AVE exchange 4 
terms converged. After convergence of AVE exchange terms, the iteration was started again 5 
for the successive time step of the same finite time interval, ∆t = 1 h. Therefore, AVE exchange 6 
terms can change for successive time steps, but remain constant during each time interval. The 7 
exchange source terms of the first iteration were initialised using the values of the previous 8 
time interval. The workflow of this nested iterative procedure was shown in fig. 2C. This 9 
procedure was repeated until cell densities of P, Q and D cells did not change (<< 0.1%) during 10 
subsequent time intervals. Usually this was reached after 400 time steps and was greatly 11 
independent of initial conditions (used for the first time interval; see supplementary Figure 3). 12 
We note that above time intervals have a specific biological interpretation within the 13 
framework of the described numerical procedure. The reason is that the procedure assumes that 14 
a certain vasculature is present and that cell compositions and their spatial distributions adapt 15 
over time starting from arbitrary initial conditions. After this adaption, time intervals refer to 16 
the speed of how cell compositions evolve in response to a change in vasculature (a 17 
disequilibrium that is given between the actual and the optimal spatiotemporal cell 18 
composition). 19 
 20 
Finally, concentration for proliferating (P), quiescent (Q) and dead cells (D) for the entire tissue 21 
were obtained by weighting the P, Q, N numbers of each AVE by the relative occurrence of 22 
the AVE and multiplying by its volume, e.g.  P= ∑ 𝑃𝐴𝑉𝐸 𝑖𝑖  ∙
𝑉𝑜𝑙𝑖∙𝜔𝑖
∑ 𝑉𝑜𝑙𝑖∙𝜔𝑖
. All calculations were 23 
performed using MATLAB R2014 (The Mathworks, UK) using the in-built PDE solver 24 
(PDEPE). Code is provided by the authors on request. 25 
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 1 
Calculation of the change of tumour proliferation characteristics for increasing 2 
microvessel density 3 
For model calculations in Fig 3, a heterogeneous vessel distribution as in Fig 3C was used. 4 
AVE size distributions were then calculated using the virtual tissue method as described above 5 
using the IVD as input. The observed experimental decrease of the microvessel distance 6 
between day 8 and day 18 by 27% was reflected by an increase of IVD by 37% due to the 7 
inverse relationship between both (IVD ~  1/MVD; 100% / 137% = 0.73, i.e. 27 % 8 
decrease). IVD values were hence chosen as 64 µm to 85 µm for day 8 and day 18, respectively, 9 
to be centred around the experimental value of 75 µm [27].  10 
 11 
Xenograft model   12 
Xenograft models were established by subcutaneous injection of 2.5 x 106 HCT116-luc2 cells 13 
into the flank of Balb/c nude mice (Charles River Laboratories, UK). Tumours were harvested 14 
at days 8 (n = 2) and 18 (n = 2) and fixed in 10 % buffered formalin for 24 hours before being 15 
processed and paraffin embedded.  16 
Histologic Examination and Immunohistochemistry 17 
Paraffin-embedded, formalin-fixed tissue sections from mouse HCT116-luc2 subcutaneous 18 
tumours were stained with Hematoxylin and Eosin (H & E) and anti-luciferase stained in order 19 
to access percentage of tumour core necrosis. Anti-KI67 and anti-PECAM1/CD31 staining 20 
procedures were carried out to determine tumour cell proliferation and microvessel density 21 
respectively. In brief, tumour sections were deparaffinized with xylene and rehydrated 22 
according to standard histologic procedures. For epitope retrieval, sections were boiled for 20 23 
minutes in 10 mM citrate buffer, pH 6.0. Sections were rinsed in Tris buffered saline (TBS)-24 
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Tween and blocked in 5 % serum in TBS for 1 hour followed by incubation at room temperature 1 
for 1 hour with the following primary antibodies: rabbit anti-Ki-67 (Millipore, Billerica, MA), 2 
dilution 1:100; goat anti-luciferase polyclonal antibody (pAb) (Promega, Fitchburg, WI), 3 
dilution 1:50; and goat anti-PECAM-1 (M-20) (Santa Cruz Biotechnology, Inc., Dallas, TX), 4 
dilution 1:100 in TBS containing 1% serum. Biotinylated goat anti-rabbit or horse anti-goat 5 
secondary antibodies (Vector Laboratories, Burlingame, CA), dilution 1:200 in TBS/ 1 % 6 
serum, were applied for 1 hour at room temperature followed by ABC complex (Vectastain 7 
ABC kit, Vector Laboratories) incubation for 30 minutes. Positive signal was developed with 8 
diaminobenzidine (DAKO, Glostrup, Denmark) according to the manufacturer’s instructions. 9 
Sections were counterstained with hematoxylin to visualize nuclei. TUNEL staining was 10 
performed according to manufacturer’s recommendations using ApoptoTag Peroxidase In Situ 11 
Apoptosis Detection Kit (Millipore, Billerica, MA). For assessment of proliferation indices 12 
(percentage of KI-67-positive cells), fractions of labelled tumour cells were assessed in 10 13 
microscopic high-power fields per section using x40 magnification and ImageJ software 14 
(National Institutes of Health, Bethesda, MD). While the rabbit anti-KI67 antibody 15 
implemented cross-reacts with human and mouse tissue,  histopathological analysis confirmed 16 
that the tumour rim area  (outside the necrotic core and the adipose tissue) used for KI67 17 
analysis in Fig 7 were almost exclusively (>95%) populated with tumour cells at both day 8 18 
and day 18, and cells with a morphology consistent with infiltrating cells are not discernible. 19 
Microvessel density based on criteria previously described [54] was assessed.  20 
To quantify percentage of tumour core necrosis, whole slides were first scanned on a Leica 21 
microsystems whole slide imaging platform (Leica Microsystems, Wetzlar, Germany) and then 22 
area of tumour core necrosis versus whole tumour area was calculated using ImageJ software 23 
(National Institutes of Health, Bethesda, MD). Alternatively, representative images of stained 24 
 Vascular tumour models studied by avascular elements 
 30  
tissue slides were captured using a Nikon 2000s epi fluorescence microscope with a 1 
Hamamatsu Orca 285 camera (Micron-Optical, Wexford, Ireland).  2 
Data Analysis 3 
Data are presented as the mean ± standard error of the mean (SEM). Two-group comparison 4 
was made using unpaired t-test or Mann Whitney test (PRISM GraphPad Software In.c., La 5 
Jolla, CA). Significance was accepted at p < 0.05. 6 
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Figure Legends 1 
Figure 1: Schematic representation of the method for decomposing vascular tissue into 2 
avascular elements (AVEs) (A) A vascular tumour is decomposed into different AVEs. Here 3 
four elements of different sizes are illustrated by different colours. (B) These elements 4 
(depicted as rectangles for convenience and colour code relating to (A), indicating different 5 
element sizes) were considered to exchange nutrients, waste and cells via diffusion. The small 6 
arrows indicate the exchange among the elements. Every AVE was assumed to be connected 7 
to an AVE of a different size with a probability proportional to their relative occurrence (C). 8 
This AVE size distribution is characterised by a histogram, whereby AVE’s are binned 9 
according their size. The shape of the histogram is an indicator of the regularity of the vessel 10 
system. (D) AVE geometry was simplified via a half cylindrical shape with a vessel at the 11 
centre and with a height being equal to the diameter of the cylinder. These assumptions reduced 12 
the mathematical complexity of the PDE system. 13 
 14 
Figure 2: Implementation of transition rates and numerical procedure (A) Scheme 15 
depicting the dependency of the three transition rates 𝑲𝑷, 𝑲𝑸 and 𝑲𝑫 on oxygen (co), glucose (cg) 16 
and lactate (waste; cw) concentrations at three different conditions. Cell death conditions (left 17 
panel) occur when either oxygen or glucose is below or waste is above a specific threshold 18 
value (Suffix T). Change from quiescence to proliferating cells occurs when concentrations 19 
exceed the proliferation threshold (medium panel; Suffix PT). Optimum conditions (Suffix opt) 20 
are achieved when, at the same time, oxygen and glucose are above and waste is below a 21 
specific concentration threshold (right panel). Between these thresholds, transition rates were 22 
interpolated using sine and cosine scaled to the descending and ascending quadrant to reflect 23 
the monotonous dependency of these rates on nutrients and wastes. (B) Transitions between 24 
proliferating (P), quiescent (Q) and dead (D) tumour cells are depicted. Above the proliferation 25 
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threshold, tumour cells proliferate at rate 𝑲𝑩 and quiescent cells become proliferating at rate 𝑲𝑷. 1 
Below the proliferation threshold, proliferating cells become quiescent at rate KQ. Below the 2 
survival threshold, quiescent cells died at rate 𝑲𝑫 and were removed according to a removal 3 
rate 𝑲𝑹. (C) The iterative procedure to calculate the AVE exchange term is depicted. A nested 4 
procedure was used. The inner iteration was used to solve Eqs. 1-3 along with Eqs. 4-9 at a 5 
certain time step t during a time interval t until AVE source terms were stable. Use of the time 6 
interval t allowed to consider the AVE exchange terms constant with respect to time during 7 
this comparably small interval. This decoupled the Eqs. 1-3 from Eqs. 4-9 in their time 8 
dependence and facilitated the numerical solution. In the outer loop, iteration was performed 9 
over subsequent time steps to account for the time dependency of AVE exchange terms. As 10 
starting conditions for each time step, AVE exchange terms of the previous step were used. 11 
The outer integration was stopped until also convergence for P, Q and D cells was achieved. 12 
Finally, the average number of P, Q and D cells per volume for a specific vascularisation were 13 
extracted. 14 
Figure 3: Calculated distribution of proliferating, quiescent and dead cells, and cell 15 
density over time emerging from homogenous and heterogeneous vascularisation (A-B) 16 
The principle of determining the relative abundance of AVEs with a characteristic diameter 17 
RAVE and its application to homogenous and heterogeneous vascularity is given. A virtual 2D 18 
tissue was assumed for homogenous (A) and heterogeneous (B) vasculature (red spots). The 19 
distance to the two nearest adjoining vessels (𝐫𝟏, 𝐫𝟐) from randomly placed dots was calculated 20 
assigning the characteristic length RAVE = ½ abs(𝐫𝟏 +  𝐫𝟐) (see magnified graph). Volumes were 21 
calculated according Fig 1D to reflect 3D avascular elements (AVE). (C) Histograms for AVE 22 
distributions using a homogenous (grey bar) or heterogeneous (black bar) vasculature from the 23 
same average vessel density were given as derived from this procedure. (D) Calculated 24 
distribution of proliferating, quiescent and dead cells for a homogenous and heterogeneous 25 
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vasculature (left column) with the same average IVD of 75 m from panel C. While under a 1 
homogenous vasculature (E; absolute numbers Q: 4.7∙108, P: 1.6∙106, D: 5.0∙105), the amount 2 
of proliferating cells was negligible, a higher amount of these cells, and therefore a higher cell 3 
turnover, was predicted with a heterogeneous distribution (absolute numbers Q: 3.0∙108, P: 4 
5.1∙107, D: 3.7∙107. (E, G) relative distribution of P (black), Q (dark grey) and D cells (light 5 
grey) in each of the 10 AVEs for homogenous and heterogeneous tissue, respectively.  Larger 6 
AVEs numbers depict bigger AVEs as characterised by the Radius RAVE from Fig 3C. For the 7 
homogenous tissue (E), only quiescent cells were present in most of the AVEs, while only the 8 
two biggest AVEs showed some dead and proliferating cells. For the heterogeneous tissue (G), 9 
proliferating cells were most prominent in the best perfused, smallest AVE, while dead cells 10 
were prominent in larger AVEs. Notably, compensatory proliferation, whereby dead cells are 11 
replaced was noted in medium size AVEs (proliferating rate higher in AVE 5-8 than in AVE 12 
3). (F, H) Volume weighted relative distribution of P, Q, D cells for the homogenous (F) and 13 
heterogeneous tissue (H) are given, giving the percentages of cells of each type and in each 14 
AVE relative to the entire tissue (100%).  15 
Figure 4: Sensitivity analysis of the model Parameters that were not obtained from literature 16 
were subjected to a local sensitivity analysis, whereby each parameter was varied 17 
independently by 10%. Parameters are described in Table 1. The heterogeneous distribution 18 
from Fig. 3 was used (average IVD of 75 m). (A-B) Values of P, Q and D cells were given 19 
relative to the tissue and absolute deviation of these relative percentages were calculate when 20 
a parameter was changed by +/- 10 % compared to the one obtained by the reference value of 21 
the parameter of Table 1. The vessel permeability was identified as the most influential 22 
parameter. Only parameters which changed the cell composition by more than 0.1% were 23 
shown. (C) Same as (AB) for the cell compositions when using a different number of AVEs. 24 
 25 
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Figure 5: Change of cell composition over different amount of vascularisation reveals a 1 
peak of proliferating and dead cells around and average IVD of 80 m (A) Cell numbers 2 
for P (black dashed line), Q (dark grey dotted line), and D (light grey solid line) cells were 3 
given for heterogeneous tissues with different average IVDs. While the average amount of cells 4 
per tissue steadily decreased due to lack of nutrient supply, the amount of proliferating cells 5 
reached a peak at about 80 m as the decreasing overall cell number at regimens between 50 6 
and 80 m allowed for quiescent cells to re-enter a proliferating state. dead cells matched that 7 
trend of proliferating cells. (B-D) Amount of oxygen (B) and glucose (C) supply together with 8 
lactate (waste, D) concentration over different heterogeneous tissues with given average IVD. 9 
Survival threshold, proliferation thresholds and optimal concentrations for the respective 10 
entities are given by dotted, small dashed and large dashed lines. Notably, oxygen levels cross 11 
the optimum proliferation threshold at ~80 m, leading to a decrease of proliferation at tissues 12 
with higher average IVD (lower vessel density). (E) Comparison of proliferating and dead cells 13 
for tissues with average IVDs of 64 and 85 that are around the peak of proliferating and dead 14 
cells. We observed an increase of 38% and 31%, respectively, despite a tissue with lower vessel 15 
density. The increase in the average IVD of 37% matched the decrease of microvessel distance 16 
in Fig 6B of 27% due to an inverse relation between both. (F, G) Volume weighted relative 17 
distribution of P, Q, D cells for a heterogeneous vessel distribution of Fig. 3C and average 18 
IVDs of 64 (F) and 85 (G) are given. The percentages of cells of each type in each AVE are 19 
given relative to the entire tissue (100%).  20 
 21 
Figure 6: Model can predict evolution of tumour cells caused by changes in vascular 22 
density Microvessel density (MVD), proliferation index and number of apoptotic cells were 23 
detected using a HCT116-luc2 SQ tumour mouse xenograft model and harvesting tumours at 24 
day 8 and 18. (A-C)  Representative images of PECAM1/CD31 staining are given (A-B). 25 
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Staining was analysed for two mice for each time point using 10 randomly chosen fields outside 1 
the necrotic core lead to a significant decrease (p = 0.0059) in MVD from Day 8 (22.4 ± 2.4) 2 
to Day 18 (16.3 ± 2.2; C). This relative decrease of 27% was considered as equal to an increase 3 
of 37% in the average IVD in our model according to their inverse relation. (D-F) Evolution 4 
of proliferating cells between day 8 and day 18. KI67 antibody was used for staining 5 
proliferating cells (D-E). A significant increase (p = 0.0006) of proliferation in day 18 tumours 6 
was observed from 19.7 ± 1.7 % (day 8) to 28.3 ± 1.6 % (day 18), as MVD decreased (F). This 7 
experimental increase in proliferating cells (44%) was matched by the model (38%). (G-I) 8 
Evolution of dead cells from day 8 to day 18 as MVD decreases. TUNEL-staining of 9 
representative fields outside the necrotic core (G-H) indicated non-significant (p = 0.098) 10 
increase in number of apoptotic cells (used to compare with the dead cells from the model) 11 
from 5.8 ± 0.7 % (day 8) to 8.0 ± 0.8 (day 18). Increase in dead cells (38%) qualitatively 12 
matched model data (31%). For all staining data bars represent mean ± SEM (day 8 (n = 10 13 
images per tumour, n = 2 animals), day 18 (n=10 images per tumour, n = 2 animals), 14 
quantifications from 10 randomly chosen field of views per section outside the necrotic core 15 
for each of the two mice sacrificed at the indicated dates, scale bar = 25 μm, * - p < 0.05, ns – 16 
non-significant, Mann-Whitney test 17 
 18 
Supplementary Figure 1: Transition rates and cellular distributions 19 
(A-B) Transition rates between P and Q in dependence on glucose and oxygen concentration 20 
relative to their optimal values (cg opt and co opt).  (C, D) Spatial distribution of the different cell 21 
types for the homogenous and the heterogeneous distribution were re-generated by randomly 22 
assigning the AVEs to spatial locations for illustration purposes. Dots were coloured according 23 
to the probability of P, Q, or D cells in the particular AVE. Islands of cell death in the 24 
heterogeneous vessel distribution in (D) indicate high accumulation of dead cells arising from 25 
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large AVE elements that were insufficiently supplied by nutrients or affected by high waste 1 
accumulation. 2 
Supplementary Figure 2: Extended sensitivity analysis  3 
Each parameter was varied independently by +/-10%. Parameters are described in Table 1. The 4 
heterogeneous distribution from Fig. 3 was used (average IVD of 75 m). (A-B) Absolute 5 
changes of P, Q and D cells were calculated when a parameter was changed by +/- 10 % and 6 
given relative to the cell composition obtained when using the reference value of the parameter 7 
of Table 1. The vessel permeability was identified as the most influential parameter (C) Same 8 
as (AB) for the cell compositions when using different numbers of AVEs. 9 
 10 
Supplementary Figure 3: Stability of our method (Fig. 2C) to initial conditions Different 11 
initial conditions were used for the heterogeneous tissue with AVE=75 of Fig 3 from the main 12 
text and temporal evolvement of P, Q and D cells and the total cell density was calculated (A-13 
D, respectively). Convergence was achieved at about 100 time steps. For the interpretation of 14 
time steps, please refer to the methods section. 15 
16 
 Vascular tumour models studied by avascular elements 
 40  
Tables 1 
Table 1: List of constants used in the model Rates for nutrient consumption, waste 2 
production, diffusion of cells and nutrients, and concentration thresholds for nutrients and 3 
waste for determining cell proliferation and death, were given along with their references. 4 
Constant Description Value/ Source 
𝑓𝑜𝑃   [mol /(ℎ . 𝑐𝑒𝑙𝑙)] Oxygen consumption of proliferating cells 3 ∙ 10
−13 [51] 
𝑓𝑔𝑃   
[mol /(ℎ . 𝑐𝑒𝑙𝑙)] Glucose consumption of proliferating cells = 162 108⁄ ∙ foP
  [31, 55] 
𝑓𝑤𝑃   [mol /(ℎ . 𝑐𝑒𝑙𝑙)] Waste production of proliferating cells =
240
108⁄ ∙ foP
 [31, 55] 
𝑓𝑜𝑄  [mol /(ℎ . 𝑐𝑒𝑙𝑙)] Oxygen consumption of quiescent cells =
50
108⁄ ∙ foP
 [31, 55] 
𝑓𝑔𝑄  
[mol /(ℎ . 𝑐𝑒𝑙𝑙)] Glucose consumption of quiescent cells = 80 50⁄ ∙ foQ
 [31, 55] 
𝑓𝑤𝑄   [mol /(ℎ . 𝑐𝑒𝑙𝑙)] Waste production of quiescent cells =
110
50⁄ ∙ foQ
 [31, 55] 
𝑓𝑜𝑁 , 𝑓𝑔𝑁 , 𝑓𝑤𝑁 Metabolic rates of dead cells 0 (assumed) 
𝐷𝑝[ cm
2/h] Empty space P cell diffusion constant 9.72 ∙ 10−7 [31] 
𝐷𝑞[ cm
2/h] Empty space Q cell diffusion constant 0.9 ∙ 𝐷𝑝 (assumed)  
𝐷𝑛[ cm
2/h] Empty space N cell diffusion constant 0 (assumed) 
𝐷𝑜[ cm
2/h] oxygen diffusion constant 5.94 ∙ 10−2 [31] 
𝐷𝑔[ cm
2/h] glucose diffusion constant 1.52 ∙ 10−3 [31] 
𝐷𝑤[ cm
2/h] waste diffusion constant 2.12 ∙ 10−3 [31] 
𝑐𝑜 𝑇[ mol /cm
3] Survival threshold for oxygen  
 
0.04 ∙ 10−6 [31] 
𝑐𝑜 𝑜𝑝𝑡[ mol /cm
3] optimal oxygen concentration  
 
0.28 ∙ 10−6 [31] 
𝑐𝑜 𝑃𝑇[ mol /cm
3] Proliferation threshold for oxygen  
𝑐𝑔 𝑃𝑇 +
(𝑐𝑔 𝑜𝑝𝑡 −  𝑐𝑔 𝑇)
3.5
 
(assumed) 
𝑐𝑔 𝑇[ mM] Survival threshold for glucose  0.06 ∙ 10
−6 [31] 
𝑐𝑔 𝑜𝑝𝑡[ mM] optimal glucose concentration  5.5 ∙ 10
−6 [31] 
𝑐𝑔 𝑃𝑇[ mM] Proliferation threshold for waste  
𝑐𝑤 𝑇 −
 𝑐𝑤 𝑇
3.5 
 
 (assumed) 
𝑐𝑤 𝑇[ mM] Survival threshold for waste  8 ∙ 10
−6 [31] 
 𝑐𝑤 𝑜𝑝𝑡[ mM] optimal glucose waste  0 [31] 
𝑐𝑤 𝑃𝑇[ mM] Proliferation threshold for glucose  
𝑐𝑤 𝑇 −
 𝑐𝑤 𝑇
3.5 
 
 (assumed) 
𝜗 [ cm2/h] Vessel permeability 18.5*Do (assumed) 
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𝐾𝑞  [1/h] 
Maximal transition rate between Q and P 
cells 
log(2)
4
 (assumed) 
𝐾𝑝 [1/h] 
Maximal transition rate between P and Q 
cells (if survival thresholds are not reached) 
log(2)
4
 (assumed) 
𝐾𝐵  [1/h] Rate of cell birth 0.047 [49] 
 
𝐾𝑟[1/h] Maximal removal rate of dead cells 
log(2)
1.5
 (assumed) 
 1 
Table 2: Limiting conditions for cell transition rates: Transition rates for the amount of 2 
quiescent cells becoming proliferating 𝐾𝑃, the amount of proliferating cells becoming 3 
quiescent 𝐾𝑄 and for the number of quiescent cells dead KD were given when different nutrient 4 
and waste concentrations converged against specific thresholds. The conditions are explained 5 
using 𝑐𝑜 as example. 6 
Situation Condition Transition 
Parameter 
Remark 
Approach 
optimum 
concen-
tration 
𝑐𝑜 𝑃𝑇 < 𝑐𝑜 → 𝑐𝑜𝑜𝑝𝑡     
𝑐𝑔 𝑃𝑇 < 𝑐𝑔 → 𝑐𝑔𝑜𝑝𝑡     
𝑐𝑤 𝑃𝑇 > 𝑐𝑤 → 𝑐𝑤𝑜𝑝𝑡    
 
if 𝑐𝑑 < 0.8 ∙ 𝑐𝑑𝑚𝑎𝑥  
 
𝐾𝑄 → 0 
𝐾𝑃 → 𝐾𝑝 
(= maximum 
value) 
𝐾𝐷 = 0 
Under optimal conditions (glucose and 
oxygen above optimum concentration 
and waste below) no proliferating cells 
become quiescent, and quiescent cells 
become proliferating with a constant 
rate 
Approach 
prolifer-
ation 
threshold 
𝑐𝑜𝑜𝑝𝑡 > 𝑐𝑜 → 𝑐𝑜 𝑃𝑇       
𝑐𝑔𝑜𝑝𝑡 > 𝑐𝑔 → 𝑐𝑔 𝑃𝑇 
𝑐𝑤𝑜𝑝𝑡 < 𝑐𝑤 → 𝑐𝑤 𝑃𝑇 
 
if 𝑐𝑑 < 0.8 ∙ 𝑐𝑑𝑚𝑎𝑥  
 
 
,   
 
 
 
𝐾𝑄 → 𝐾𝑞 
𝐾𝑃 → 0 
𝐾𝐷 = 0 
If conditions approach the proliferation 
threshold the transition rate of 
proliferating to quiescent cells becomes 
a constant 
Approach 
survival 
threshold 
 
𝑐𝑜 𝑃𝑇 > 𝑐𝑜 → 𝑐𝑜 𝑇 
𝑐𝑔 𝑃𝑇 > 𝑐𝑔 → 𝑐𝑔 𝑇 
𝑐𝑤 𝑃𝑇 < 𝑐𝑤 → 𝑐𝑤 𝑇 
if 𝑐𝑑 < 0.8 ∙ 𝑐𝑑𝑚𝑎𝑥  
 
 
𝐾𝑄 = 𝐾𝑞 
𝐾𝑃 = 0 
𝐾𝐷 = 0 
Above the survival threshold the cell 
death rate starts is still zero 
Below 
survival 
threshold  
𝑐𝑜 𝑇 > 𝑐𝑜 → 0 
𝑐𝑔 𝑇 > 𝑐𝑔 → 0 
𝑐𝑤 𝑇 < 𝑐𝑤 → ∞ 
 
𝐾𝑄 → ∞ 
𝐾𝐷 → ∞ 
𝐾𝑃 = 0 
 
If conditions demand cell death, all 
proliferating cells had to become 
quiescent first and all quiescent cells die 
immediately 
Increasing 
cell density 
𝑐𝑑 → 𝑐𝑑𝑚𝑎𝑥 
 
𝐾𝑃 → 0 
𝐾𝑄 ↑ 
𝐷𝑃 , 𝐷𝑄,𝐷𝑁 → 0  
Under lack of space the number of 
proliferating cells and cell diffusion 
vanishes. See Table 4 for specifics. 
 7 
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Table 3: Transition rates for general situation: Transition rates were given for the amount 1 
of quiescent cells becoming proliferating 𝐾𝑃, the amount of proliferating cells becoming 2 
quiescent 𝐾𝑄 and for the number of quiescent cells dead 𝐾𝐷, when no concentration approaches 3 
a threshold. Rates were determined by their most restrictive factor 𝐾?̃? = 𝑚𝑎𝑥[𝐾𝑄𝑜, 𝐾𝑄𝑔, 𝐾𝑄𝑤], 4 
𝐾?̃? = 𝑚𝑖𝑛[𝐾𝑃𝑜 , 𝐾𝑃𝑔, 𝐾𝑃𝑤], 𝐾?̃? = 𝑚𝑎𝑥[𝐾𝐷𝑜 , 𝐾𝐷𝑔, 𝐾𝐷𝑤] and corrected for the amount of 5 
available space according Table  4. 6 
Limiting factor Condition Transition Parameter Values 
Oxygen Below optimum, but above 
proliferation threshold 
𝑐𝑜 𝑃𝑇 < co < 𝑐𝑜 𝑜𝑝𝑡 
𝐾𝑄𝑜 = 𝐾𝑞 ∙ cos (
𝜋
2
∙
𝑐𝑜 − 𝑐𝑜𝑃𝑇
𝑐𝑜𝑜𝑝𝑡 − 𝑐𝑜𝑃𝑇
)
2
 
𝐾𝑃𝑜 = 𝐾𝑝 ∙ sin (
𝜋
2
∙
𝑐𝑜 − 𝑐𝑜 𝑃𝑇
𝑐𝑜_𝑜𝑝𝑡 − 𝑐𝑜 𝑃𝑇
)2 
𝐾𝐷𝑜 = 0 
Oxygen Below proliferation, but 
above survival threshold 
𝑐𝑜 𝑇 < co < 𝑐𝑜 𝑃𝑇 
𝐾𝑄𝑜 = 𝐾𝑞𝐾𝑃𝑜 = 0 
𝐾𝐷𝑜 = 0 
Oxygen Below survival threshold 
0 < co < 𝑐𝑜 𝑇 
𝐾𝑄𝑜 = 𝐾𝑞 + (
𝑐𝑜 𝑇
𝑐𝑜
− 1)
2
 
 𝐾𝑃𝑜 = 0 
𝐾𝐷𝑜 = 6 ∙ (
𝑐𝑜 𝑇
𝑐𝑜
− 1)
2
 
Glucose Below optimum, but above 
proliferation threshold 
𝑐𝑔 𝑃𝑇 < cg < 𝑐𝑔 𝑜𝑝𝑡 
𝐾𝑄𝑔 = 𝐾𝑞 ∙ cos (
𝜋
2
∙
𝑐𝑔 − 𝑐𝑔𝑃𝑇
𝑐𝑔𝑜𝑝𝑡 − 𝑐𝑔𝑃𝑇
)
2
 
𝐾𝑃𝑔 = 𝐾𝑝 ∙ sin (
𝜋
2
∙
𝑐𝑔 − 𝑐𝑔𝑃𝑇
𝑐𝑔𝑜𝑝𝑡 − 𝑐𝑔𝑃𝑇
)
2
 
 𝐾𝐷𝑔 = 0 
Glucose Below proliferation, but 
above survival threshold 
𝑐𝑔 𝑇 < cg < 𝑐𝑔 𝑃𝑇 
𝐾𝑄𝑔 = 𝐾𝑞 
 𝐾𝑃𝑔 = 0   
𝐾𝐷𝑔 = 0 
Glucose Below survival threshold 
0 < cg < 𝑐𝑔 𝑇 
𝐾𝑄𝑔 = 𝐾𝑞 + (
𝑐𝑔 𝑇
𝑐𝑔
− 1)
2
 
 𝐾𝑃𝑜 = 0 
𝐾𝐷𝑜 = 6 ∙ (
𝑐𝑔 𝑇
𝑐𝑔
− 1)
2
 
Waste Below optimum, but above 
proliferation threshold 
𝑐𝑤 𝑃𝑇 > cw > 𝑐𝑤 𝑜𝑝𝑡 
𝐾𝑄𝑤 = 𝐾𝑞 ∙ cos (
𝜋
2
∙
−𝑐𝑤 + 𝑐𝑤𝑃𝑇
𝑐𝑤𝑜𝑝𝑡 − 𝑐𝑤𝑃𝑇
)
2
 
𝐾𝑃𝑤 = 𝐾𝑝 ∙ sin (
𝜋
2
∙
−𝑐𝑤 + 𝑐𝑤𝑃𝑇
𝑐𝑤𝑜𝑝𝑡 − 𝑐𝑤𝑃𝑇
)
2
 
 𝐾𝐷𝑤 = 0 
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Waste Below proliferation, but 
above survival threshold 
𝑐𝑤 𝑇 > cw > 𝑐𝑤 𝑃𝑇 
𝐾𝑄𝑤 = 𝐾𝑞  
𝐾𝑃𝑤 = 0   
𝐾𝐷𝑤 = 0 
Waste Below survival threshold 
0 > cw > 𝑐𝑤 𝑇 
𝐾𝑄𝑤 = 𝐾𝑞 + (
cw
𝑐𝑤 𝑇
− 1)
2
 
 𝐾𝑃𝑤 = 0 
𝐾𝐷𝑤 = 6 ∙ (
cw
𝑐𝑤 𝑇
− 1)
2
 
 1 
Table 4: Correction of transition rates in dependence on available space Transition rates 2 
of Equation 4 and Table 3 were corrected for the amount of cell density (cd). Free space was 3 
assumed whenever the total concentration of cells was below 𝑏1 =  4.0 ∙ 10
8 [cells cm3⁄ ], 4 
while full space was assumed was assumed whenever the total cell density exceeded  𝑏2 =5 
 4.5 ∙ 108  [cells cm3⁄ ]. 6 
𝑐𝑑 <  𝑏1 𝐾𝑃 = 𝐾?̃? 
 𝑏1 < 𝑐𝑑 < 𝑐𝑑𝑚𝑎𝑥 
𝐾𝑃 = 𝐾?̃? ∙ cos (
𝜋
2
∙
𝑐𝑑 −  𝑏1
𝑐𝑑𝑚𝑎𝑥
)
2
 
𝑐𝑑 <  𝑏2 𝐾𝑄 = 𝐾?̃? 
𝑐𝑑 >  𝑏2 
𝐾𝑄 = 𝐾?̃? ∙ 100 ∙ (
 𝑏2 − 𝑐𝑑
𝑐𝑑𝑚𝑎𝑥
)
2
 
 7 
Table 5: Boundary conditions for nutrient distributions: Homogenous boundary conditions 8 
were assumed to mimic optimum oxygen and glucose supply as well as maximum waste 9 
disposal for the AVE at the vessel location (𝑟 = 𝑟𝑣𝑒𝑠𝑠𝑒𝑙 , i.e. at the vessel surface). Migration of 10 
cells between the vessel and the tumour were disregarded. Likewise, no flow of cells and 11 
nutrients waste was assumed. However, source term correction for cells and nutrients was 12 
considered as described in the text. 13 
Boundary condition at vessel 
Boundary condition at 
surface 
∇ 𝑐𝑜(𝑟=𝑟𝑣𝑒𝑠𝑠𝑒𝑙)
=
𝜗
𝐷𝑜
∙  (𝑐𝑜𝑣𝑒𝑠𝑠𝑒𝑙 − 𝑐𝑜(𝑟=𝑟𝑣𝑒𝑠𝑠𝑒𝑙)) 
 
∇𝑃(𝑟=𝑟𝑣𝑒𝑠𝑠𝑒𝑙) = 0 ∇ 𝑐𝑜(𝑟=𝑅)
= 0 
 
∇𝑃(𝑟=𝑅) = 0 
∇ 𝑐𝑔(𝑟=𝑟𝑣𝑒𝑠𝑠𝑒𝑙)
=
𝜗
𝐷𝑔
∙  (𝑐𝑔𝑣𝑒𝑠𝑠𝑒𝑙 − 𝑐𝑔(𝑟=𝑟𝑣𝑒𝑠𝑠𝑒𝑙)) 
 
∇𝑄(𝑟=𝑟𝑣𝑒𝑠𝑠𝑒𝑙) = 0 ∇ 𝑐𝑔(𝑟=𝑅)
= 0 
 
∇𝑄(𝑟=𝑅) = 0 
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∇ 𝑐𝑤(𝑟=𝑟𝑣𝑒𝑠𝑠𝑒𝑙)
=
𝜗
𝐷𝑤
∙  (𝑐𝑤𝑣𝑒𝑠𝑠𝑒𝑙 − 𝑐𝑤(𝑟=𝑟𝑣𝑒𝑠𝑠𝑒𝑙)) 
 
∇𝐷(𝑟=𝑟𝑣𝑒𝑠𝑠𝑒𝑙) = 0 ∇ 𝑐𝑝(𝑟=𝑅)
= 0 
 
∇𝐷(𝑟=𝑅) = 0 
 1 
  2 
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Figure 1 1 
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Figure 41 
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Figure 5 1 
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Figure 6 1 
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